BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21401208)

  • 1. Identification of vascular breast tumor markers by laser capture microdissection and label-free LC-MS.
    Hill JJ; Tremblay TL; Pen A; Li J; Robotham AC; Lenferink AE; Wang E; O'Connor-McCourt M; Kelly JF
    J Proteome Res; 2011 May; 10(5):2479-93. PubMed ID: 21401208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
    Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of breast cancer tissues to identify biomarker candidates by gel-assisted digestion and label-free quantification methods using LC-MS/MS.
    Song MN; Moon PG; Lee JE; Na M; Kang W; Chae YS; Park JY; Park H; Baek MC
    Arch Pharm Res; 2012 Oct; 35(10):1839-47. PubMed ID: 23139137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics of Grade 3 infiltrating ductal carcinoma in Malaysian Chinese breast cancer patients.
    Othman MI; Majid MI; Singh M; Subathra S; Seng L; Gam LH
    Biotechnol Appl Biochem; 2009 Mar; 52(Pt 3):209-19. PubMed ID: 18564057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
    Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM
    BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, identification and quantification of differentially expressed proteins from cancerous and normal breast tissues.
    Othman MI; Majid MI; Singh M; Man CN; Lay-Harn G
    Ann Clin Biochem; 2008 May; 45(Pt 3):299-306. PubMed ID: 18482919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection.
    Neubauer H; Clare SE; Kurek R; Fehm T; Wallwiener D; Sotlar K; Nordheim A; Wozny W; Schwall GP; Poznanović S; Sastri C; Hunzinger C; Stegmann W; Schrattenholz A; Cahill MA
    Electrophoresis; 2006 May; 27(9):1840-52. PubMed ID: 16645950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NanoLC-FT-ICR MS improves proteome coverage attainable for approximately 3000 laser-microdissected breast carcinoma cells.
    Umar A; Luider TM; Foekens JA; Pasa-Tolić L
    Proteomics; 2007 Jan; 7(2):323-9. PubMed ID: 17163580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of manganese superoxide dismutase in patients with breast cancer.
    Tsai SM; Hou MF; Wu SH; Hu BW; Yang SF; Chen WT; Chai CY; Ma H; Tsai LY
    Kaohsiung J Med Sci; 2011 May; 27(5):167-72. PubMed ID: 21527182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of infiltrating ductal carcinoma reveals increased cellular interactions with tissue microenvironment.
    Gormley M; Tchafa A; Meng R; Zhong Z; Quong AA
    J Proteome Res; 2012 Apr; 11(4):2236-46. PubMed ID: 22356716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser capture microdissection applications in breast cancer proteomics.
    Braakman RB; Luider TM; Martens JW; Foekens JA; Umar A
    Methods Mol Biol; 2011; 755():143-54. PubMed ID: 21761300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression analysis of periostin in human breast cancer.
    Zhang Y; Zhang G; Li J; Tao Q; Tang W
    J Surg Res; 2010 May; 160(1):102-6. PubMed ID: 19524268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of protein identification of selected cell types in Barrett's esophagus analyzed by combining laser-capture microdissection and mass spectrometry.
    Stingl C; van Vilsteren FG; Guzel C; Ten Kate FJ; Visser M; Krishnadath KK; Bergman JJ; Luider TM
    J Proteome Res; 2011 Jan; 10(1):288-98. PubMed ID: 21053923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS.
    Haqqani AS; Nesic M; Preston E; Baumann E; Kelly J; Stanimirovic D
    FASEB J; 2005 Nov; 19(13):1809-21. PubMed ID: 16260651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
    Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
    Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host response to human breast Invasive Ductal Carcinoma (IDC) as observed by changes in the stromal proteome.
    Reddy LA; Mikesh L; Moskulak C; Harvey J; Sherman N; Zigrino P; Mauch C; Fox JW
    J Proteome Res; 2014 Nov; 13(11):4739-51. PubMed ID: 25244421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue.
    Röwer C; Vissers JP; Koy C; Kipping M; Hecker M; Reimer T; Gerber B; Thiesen HJ; Glocker MO
    Anal Bioanal Chem; 2009 Dec; 395(8):2443-56. PubMed ID: 19876624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.